NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ProFound Therapeutics

ProFound Therapeutics

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.profoundtx.com/

Last Round

Corporate Funding

Jun 26, 2025

Total Funding Raised

$75M

Company Overview

ProFound Therapeutics is a biotechnology company that utilizes its proprietary ProFoundry™ Platform to systematically discover and validate novel proteins within the expanded human proteome for the development of first-in-class medicines.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

proteomicsdrug discoveryai drug discoverytarget identificationbiotech platformin-silico drug discoverytherapeutic target discoveryproteome mappingfirst-in-class therapeuticsmachine learningcomputational biologybiotech partnershipdrug pipelinetranslatomicspharma r&d

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ProFound Therapeutics Comparables

Compare ProFound Therapeutics with similar companies based on industry and business-model similarity.

ProFound Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Quotient Therapeutics
88%
Protai
83%
Vesalius Therapeutics
82%

ProFound Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingJun 26, 2025
Series AMay 26, 2022

Key People

Founding team and executive leadership

Vinidhra Mani

Co-Founder And Chief Innovation Officer

Founding Team

John Lepore

Chief Executive Officer

Executive Team

Tom Chittenden

Chief Technology Officer

Executive Team

ProFound Therapeutics Investors

Notable investors and investment history

ProFound Therapeutics investors
InvestorRounds
NotleySeries A
Flagship PioneeringSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 26, 2025

    $25M raised in corporate funding.

  • Jun 26, 2025

    Four-year deal to discover and develop novel therapeutics for cardiovascular disease.

ProFound Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ProFound Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ProFound Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range51
Year Founded2020
Last FundingJun 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.